Recent Quotes

My Watchlist

Top Indices

My Portfolio

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Lululemon Founder Pins Pullback Of Sheer Training Pants On Board’s Lack Of Experience, Calls It ‘A New Low’ ↗

Today 18:50 EST

Via Stocktwits

1 Growth Stock Down 19% to Buy Right Now ↗

Today 16:35 EST

Via The Motley Fool

Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine

Today 15:06 EST

Via TokenRing AI

IBRX Stock Extends Rally On FDA Feedback For ANKTIVA Bladder Cancer Filing ↗

January 20, 2026

Via Stocktwits

Apellis Valuation Ignores Empaveli Potential, Says Analyst ↗

Today 13:14 EST

Via Benzinga

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface ↗

Today 12:30 EST

Via Benzinga

Moderna (MRNA) Shares Skyrocket, What You Need To Know

Today 12:21 EST

Via StockStory

DBLG2 from Diabeloop Becomes the First Automated Insulin Delivery (AID) Cleared by FDA and CE Mark Where Meal Announcements Are No Longer Mandatory

Today 11:02 EST

Via Get News

The New Wegovy Pill Is Already Popular. Does That Make Novo Nordisk Stock a Buy for Q1?

Today 10:00 EST

Via Barchart.com

FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer ↗

Today 9:35 EST

Via Benzinga

4 Smart Tips to Save Money and Stay Well This Season

Today 1:00 EST

Via StatePoint Media

Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer ↗

January 20, 2026

Via The Motley Fool

GE Aerospace Eyes Post-Spin 'Super-Cycle' Peak as Q4 Earnings Approach

January 20, 2026

Via MarketMinute

The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation

January 20, 2026

Via MarketMinute

Valneva Steps Back From US Approval Bid For Chikungunya Vaccine ↗

January 20, 2026

Via Benzinga

Bill Gates Recalls Warren Buffett Treating Him to McDonald's — Then Paying With Coupons ↗

January 20, 2026

Via Benzinga

Lululemon Stock Slips 6% After Reportedly Removing “See-Through” Leggings From Website ↗

January 20, 2026

Via Stocktwits

CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗

January 20, 2026

Via Stocktwits

FDA Talks Set Path For Expanded Use For ImmunityBio's Anktiva In Bladder Cancer ↗

January 20, 2026

Via Benzinga

FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain ↗

January 20, 2026

Via Benzinga

Moment of Clarity Publishes New Resource on Insurance Acceptance for SPRAVATO® Treatment

January 20, 2026

Via Press Advantage

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Receives FDA Orphan Drug Designation For LP-284 In Soft Tissue Sarcomas

January 20, 2026

Via Investor Brand Network

The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion

January 20, 2026

Via MarketMinute

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor

January 20, 2026

Via NewMediaWire

AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor

January 20, 2026

Via TheNewswire.com

INVO Fertility’s 350% Spike Puts Microcap IVF Stocks Back On Retail Radar ↗

January 20, 2026

Via Stocktwits

Why Is ImmunityBio Stock Back In Retail Spotlight Today? ↗

January 19, 2026

Via Stocktwits

Why Is Cadrenal Therapeutics Stock Drawing Retail Attention Today? ↗

January 19, 2026

Via Stocktwits

The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies

January 19, 2026

Via TokenRing AI

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.